Evidence map›Paper›PMID 38086374›Full record

ArticleNeuron2024

Mesoaccumbal glutamate neurons drive reward via glutamate release but aversion via dopamine co-release.

Shelley M Warlow, Sarthak M Singhal, Nick G Hollon, Lauren Faget, Dina S Dowlat, Vivien Zell, Avery C Hunker, Larry S Zweifel, Thomas S Hnasko

Open access · bronzeAbstract read
In one paragraph

Article in Neuron, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Salience Signaling and Stimulus Scaling of Ventral Tegmental Area Glutamate Neuron Subtypes.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  17. Modulation of Dopamine Neurons Alters Behavior and Event Encoding in the Nucleus Accumbens during Pavlovian Conditioning.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  18. Article
  19. Article
  20. Untangling dopamine and glutamate in the ventral tegmental area.bioRxiv : the preprint server for biology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Shelley M WarlowDepartment of Neurosciences, University of California, San Diego, La Jolla, CA, USA.
Sarthak M SinghalDepartment of Neurosciences, University of California, San Diego, La Jolla, CA, USA.
Nick G HollonDepartment of Psychiatry, University of California, San Diego, La Jolla, CA, USA.
Lauren FagetDepartment of Neurosciences, University of California, San Diego, La Jolla, CA, USA.
Dina S DowlatDepartment of Neurosciences, University of California, San Diego, La Jolla, CA, USA.
Vivien ZellDepartment of Neurosciences, University of California, San Diego, La Jolla, CA, USA.
Avery C HunkerDepartment of Pharmacology, University of Washington, Seattle, WA, USA.
Larry S ZweifelDepartment of Pharmacology, University of Washington, Seattle, WA, USA.
Thomas S HnaskoDepartment of Neurosciences, University of California, San Diego, La Jolla, CA, USA; Veterans Affairs San Diego Healthcare System, San Diego, CA, USA. Electronic address: thnasko@health.ucsd.edu.
University of California San Diego · USUniversity of Washington · USUC San Diego Health System · US

Funding

University of Washington Center of Excellence in Opioid Addiction ResearchP30DA048736 · NIDA · UNIVERSITY OF WASHINGTON · PI Charles Chavkin · 2019 to 2026
$13.0M
Role of novel VTA neurons in addiction-related behaviorsR01DA036612 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Thomas Hnasko · 2014 to 2026
$5.6M
Balancing motivation through VTA GABA/Glutamate co-transmissionK99MH130688 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI WARLOW, SHELLEY MAY · 2022 to 2023
$295k
The role of VTA neurotransmitter co-release in health and diseaseF32MH122192 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI WARLOW, SHELLEY MAY · 2019 to 2022
$178k
Neurophysiological Characterization of Novel Neurotensin Receptor Ligands to Define Therapeutic Potential in Combatting AddictionI01BX003759 · VA · VA SAN DIEGO HEALTHCARE SYSTEM · PI HNASKO, THOMAS · 2018 to 2022
–
Midbrain neural circuit mechanisms underlying addictionI01BX005782 · VA · VA SAN DIEGO HEALTHCARE SYSTEM · PI HNASKO, THOMAS · 2022 to 2025
–
BLRD VA I01 BX003759BLRD VA I01 BX005782NIDA NIH HHS P30 DA048736NIDA NIH HHS R01 DA036612NIMH NIH HHS F32 MH122192NIMH NIH HHS K99 MH130688
6 · The paper itself

Abstract

Ventral tegmental area (VTA) projections to the nucleus accumbens (NAc) drive reward-related motivation. Although dopamine neurons are predominant, a substantial glutamatergic projection is also present, and a subset of these co-release both dopamine and glutamate. Optogenetic stimulation of VTA glutamate neurons not only supports self-stimulation but can also induce avoidance behavior, even in the same assay. Here, we parsed the selective contribution of glutamate or dopamine co-release from VTA glutamate neurons to reinforcement and avoidance. We expressed channelrhodopsin-2 (ChR2) in mouse VTA glutamate neurons in combination with CRISPR-Cas9 to disrupt either the gene encoding vesicular glutamate transporter 2 (VGLUT2) or tyrosine hydroxylase (Th). Selective disruption of VGLUT2 abolished optogenetic self-stimulation but left real-time place avoidance intact, whereas CRISPR-Cas9 deletion of Th preserved self-stimulation but abolished place avoidance. Our results demonstrate that glutamate release from VTA glutamate neurons is positively reinforcing but that dopamine release from VTA glutamate neurons can induce avoidance behavior.

Indexed as

DopamineGlutamic AcidAnimalsDopaminergic NeuronsMiceRewardTyrosine 3-MonooxygenaseVentral Tegmental AreaVesicular Glutamate Transport Protein 2DopamineGlutamic AcidTyrosine 3-MonooxygenaseVesicular Glutamate Transport Protein 2CRISPR-Cas9dopamineglutamatereinforcementrewardventral tegmental areaVGLUT2

Identifiers

PMID38086374
PMCPMC10922836
OpenAlexW4389573301

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.